Market Tracker

05/27 10:02am ET

Clovis Oncology Inc (NASDAQ:CLVS)

16.44
Delayed Data
As of May 26
 +0.44 / +2.75%
Today’s Change
11.58
Today|||52-Week Range
116.75
-53.03%
Year-to-Date
Kyle Bass Purchases Stake in Clovis Oncology
May 25 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close16.00
Today’s open16.00
Day’s range15.97 - 16.80
Volume1,300,103
Average volume (3 months)1,321,443
Market cap$614.2M
Dividend yield--
Data as of 05/26/2016

Growth & Valuation

Earnings growth (last year)-107.42%
Earnings growth (this year)+17.86%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book2.04

Competitors

 Today’s
change
Today’s
% change
EPZMEpizyme Inc-0.25-2.31%
DVAXDynavax Technologies...-0.25-1.55%
KERXKeryx Biopharmaceuti...+0.01+0.18%
CORTCorcept Therapeutics...-0.04-0.73%
Data as of 05/26/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$2.14
Annual revenue (last year)$0.00
Annual profit (last year)-$352.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
VP, Chief Financial &
Accounting Officer
Daniel W. Muehl
Corporate headquarters
Boulder, Colorado

Forecasts